Purpose of review The number of cancer patients grows globally. An important subset may
develop heart failure. Recent findings A paucity of data exists regarding outcomes and …

Abstract Purpose of Review Heart failure and cancer share common risk factors. We sought
to describe outcomes of advanced heart failure therapies in the cardio-oncology population …

Heart failure aVects up to 2% of the adult population. 1 Interestingly, this rate is remarkably
consistent in diVerent populations throughout the world. It does not matter how aZuent a …

Cancer and cardiovascular disease account for nearly half of all deaths in the US. The
majority of cancer therapies are known to cause potential cardiac toxicity in some form …

Large observational studies indicate that as many as 15-25% of patients with heart failure
(HF) have a history of cancer (1, 2), and many may have more active cancers requiring …

Over the past decade, evolving cancer treatments have resulted in improved overall survival.
It is estimated that there are approximately 15 million cancer survivors in the United States …

Heart failure (HF) is currently defined as a complex clinical syndrome that results from any
structural or functional impairment of ventricular filling or ejection of blood. 1 This condition …

Heart failure is a complex clinical syndrome, whose signs and symptoms are caused by
functional or structural impairment of ventricular filling or ejection of blood. Due to the …

Advances in cancer treatments have improved clinical outcomes, leading to an increasing
population of cancer survivors. However, this success is associated with high rates of short …

Opinion statement Rapid improvement in antineoplastic therapy is increasing not only
cancer survivorship but also the incidence of end-stage heart failure among breast and …